Page last updated: 2024-08-26

nicotine and 15-keto-13,14-dihydroprostaglandin e2

nicotine has been researched along with 15-keto-13,14-dihydroprostaglandin e2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
al'Absi, M; Benowitz, NL; Carmella, SG; Cinciripini, PM; Donny, EC; Drobes, DJ; Hatsukami, DK; Hecht, SS; Heskin, AK; Ikuemonisan, J; Jensen, J; Koopmeiners, J; Leischow, S; Luo, X; Robinson, JD; Strasser, AA; Tang, MK; Vandrey, R	1

Trials

1 trial(s) available for nicotine and 15-keto-13,14-dihydroprostaglandin e2

Article	Year
Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects. Addiction (Abingdon, England), 2019, Volume: 114, Issue:10 Topics: Adult; Bayes Theorem; Biomarkers; C-Reactive Protein; Cigarette Smoking; Dinoprost; Dinoprostone; Erythrocyte Count; Erythrocyte Indices; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxidative Stress; Platelet Count; Smoking Reduction; Tobacco Products	2019

Article

Year

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Addiction (Abingdon, England), 2019, Volume: 114, Issue:10

Topics: Adult; Bayes Theorem; Biomarkers; C-Reactive Protein; Cigarette Smoking; Dinoprost; Dinoprostone; Erythrocyte Count; Erythrocyte Indices; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxidative Stress; Platelet Count; Smoking Reduction; Tobacco Products

2019